Brachytherapy
Volume 7, Issue 2 , Page 93, April 2008

Interstitial high-dose-rate brachytherapy + IMRT vs. HDR monotherapy for early stage prostate cancer

  • Rufus J. Mark, M.D.

      Affiliations

    • Radiation Oncology, Joe Arrington Cancer Center, Lubbock, TX
    • Radiation Oncology, Texas Tech University Medical Center, Lubbock, TX
    • ,
  • Paul J. Anderson, M.D.

      Affiliations

    • Radiation Oncology, Joe Arrington Cancer Center, Lubbock, TX
    • ,
  • Robin S. Akins, M.D.

      Affiliations

    • Radiation Oncology, University of Miami, Miami, FL
    • ,
  • Murali Nair, Ph.D.

      Affiliations

    • Radiation Oncology, Joe Arrington Cancer Center, Lubbock, TX
    • Radiation Oncology, Texas Tech University Medical Center, Lubbock, TX

OR3 Presentation Time: 3:20 PM

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1538-4721(08)00395-4

doi:10.1016/j.brachy.2008.02.339

Brachytherapy
Volume 7, Issue 2 , Page 93, April 2008

Article Tools